Streetbeat News

Price Targets

CLSK

Cantor Fitzgerald analyst Josh Siegler has reiterated an Overweight rating on Cleanspark (NASDAQ:CLSK) and maintained a $10 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 3:18 pm

CIFR

Cantor Fitzgerald analyst Josh Siegler has reiterated an Overweight rating on Cipher Mining (NASDAQ:CIFR) and maintained a $6 price target for the company.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 3:16 pm

BITF

Cantor Fitzgerald analyst Josh Siegler has reiterated an Overweight rating on Bitfarms (NASDAQ:BITF) and maintained a $2 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 3:13 pm

IOT

Samsara (NYSE:IOT) has received 10 analyst ratings in the last quarter, with an average price target of $32.6, which is below its current price of $34.6568, suggesting a downside. The ratings include 2 bullish, 4 somewhat bullish, and 4 indifferent, with no bearish ratings. The average price target has increased by 10.51% over the past month. Analyst ratings are based on future earnings predictions and company risk assessments, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 3:01 pm

YPF

Over the last quarter, YPF (NYSE:YPF) received 6 analyst ratings, with 4 being indifferent and 2 bearish. No bullish ratings were given. The 12-month price target for YPF averages $14.27, with a high of $20.00 and a low of $8.50. This target has increased by 40.45% in the past month. Analysts rate stocks based on research and provide guidance on growth estimates, earnings, and revenue.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 3:00 pm

VRDN

Viridian Therapeutics (NASDAQ:VRDN) received 8 analyst ratings in the last quarter, with 2 bullish and 6 somewhat bullish, and none bearish. The average 12-month price target is $37.25, with a high of $46.00 and a low of $30.00, representing a 13.37% decrease from the previous target of $43.00. Analysts are specialists who provide ratings and forecasts for stocks, and their opinions are a mix of analysis and personal belief.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 3:00 pm

FICO

Fair Isaac (NYSE:FICO) has received various analyst ratings over the last quarter, with 1 bullish, 4 somewhat bullish, 1 indifferent, and 1 somewhat bearish rating. The average 12-month price target among 7 analysts is $1019.71, which is a slight decrease from the previous target of $1022.00. Analysts provide these ratings based on research and forecasts, which can influence investor decisions.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 3:00 pm

SGHT

Sight Sciences (NASDAQ:SGHT) has received mixed ratings from analysts in the last quarter, with 1 bullish, 5 indifferent, and 2 somewhat bearish ratings. The average 12-month price target from 8 analysts is $4.31, which is a significant 50.35% decrease from the previous target of $8.68. Analysts use various methods to forecast stock performance, including company data and industry trends.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 3:00 pm

STE

Analysts have provided ratings for Steris (NYSE:STE) with 2 somewhat bullish and 3 indifferent ratings in the last quarter. The average 12-month price target for Steris is $232.00, with a high of $265.00 and a low of $215.00, marking a 4.66% increase from the previous target of $221.67. Analyst ratings are updated quarterly and are based on financial analysis and insider information.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 3:00 pm

UNCY

Benchmark analyst Bruce Jackson reiterated a Speculative Buy rating on Unicycive Therapeutics (NASDAQ:UNCY) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 2:59 pm